Tracy Saxton

Directeur Général chez Aucupo Biosciences, Inc.

Profil

Tracy Saxton is the founder of Aucupo Biosciences, Inc. She is currently a Fellow at The Damon Runyon Cancer Research Foundation.
Previously, she held positions as a Director at Millendo Therapeutics US, Inc., PanOptica, Inc., and MISSION Therapeutics Ltd.
She was also a Principal at Amgen, Inc., Geron Corp., Tularik, Inc., Threshold Pharmaceuticals, Inc., Cyterix Pharmaceuticals, Inc., and Rempex Pharmaceuticals, Inc. Additionally, she served as an Investment Director at Roche Ventures from 2015 to 2017 and as a Managing Director at Dolby Family Ventures LLC from 2020 to 2022.
She was a Director at Vaxcyte, Inc., Entasis Therapeutics, Inc., and Lengo Therapeutics, Inc. from 2017 to 2017, 2019 to 2021, and 2017 to 2017, respectively.
She also worked as a Managing Partner at Pivotal Bioventure Partners Investment Advisor LLC in 2017.
Dr. Saxton holds an MBA from The Trustees of Columbia University in The City of New York, an undergraduate degree from Simon Fraser University, and a doctorate from the University of Toronto.

Postes actifs de Tracy Saxton

Sociétés	Poste	Début
The Damon Runyon Cancer Research Foundation	Corporate Officer/Principal	-
Aucupo Biosciences, Inc.	Directeur Général	-

Anciens postes connus de Tracy Saxton

Sociétés	Poste	Fin
Dolby Family Ventures LLC	Private Equity Investor	30/06/2022
Lengo Therapeutics, Inc.	Directeur Général	-
Pivotal Bioventure Partners Investment Advisor LLC	Private Equity Investor	31/12/2017
Entasis Therapeutics, Inc.	Directeur/Membre du Conseil	01/12/2017
Roche Ventures	Private Equity Investor	31/01/2017

Formation de Tracy Saxton

Simon Fraser University	Undergraduate Degree
University of Toronto	Doctorate Degree
The Trustees of Columbia University in The City of New York	Masters Business Admin